These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 24820774)

  • 1. GABA receptors in brain development, function, and injury.
    Wu C; Sun D
    Metab Brain Dis; 2015 Apr; 30(2):367-79. PubMed ID: 24820774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate and GABA receptor signalling in the developing brain.
    Luján R; Shigemoto R; López-Bendito G
    Neuroscience; 2005; 130(3):567-80. PubMed ID: 15590141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic developmental rules and their implications for epilepsy in the immature brain.
    Ben-Ari Y
    Epileptic Disord; 2006 Jun; 8(2):91-102. PubMed ID: 16793570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel dose-dependent alterations in excitatory GABA during embryonic development associated with lead (Pb) neurotoxicity.
    Wirbisky SE; Weber GJ; Lee JW; Cannon JR; Freeman JL
    Toxicol Lett; 2014 Aug; 229(1):1-8. PubMed ID: 24875535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural mechanisms underlying GABAergic regulation of adult hippocampal neurogenesis.
    Catavero C; Bao H; Song J
    Cell Tissue Res; 2018 Jan; 371(1):33-46. PubMed ID: 28948349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABAergic signalling in the immune system.
    Barragan A; Weidner JM; Jin Z; Korpi ER; Birnir B
    Acta Physiol (Oxf); 2015 Apr; 213(4):819-27. PubMed ID: 25677654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited.
    Marczynski TJ
    Brain Res Bull; 1998; 45(4):341-79. PubMed ID: 9527011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the GABAergic system from birth to adolescence.
    Kilb W
    Neuroscientist; 2012 Dec; 18(6):613-30. PubMed ID: 21952258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rhythmic GABAergic system.
    Cardinali DP; Golombek DA
    Neurochem Res; 1998 May; 23(5):607-14. PubMed ID: 9566598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tonic GABAergic currents during pre- and early postnatal rodent development.
    Kilb W; Kirischuk S; Luhmann HJ
    Front Neural Circuits; 2013; 7():139. PubMed ID: 24027498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of GABA(A) receptor heterogeneity: clues from developing neurons.
    Fritschy JM
    Adv Pharmacol; 2015; 73():13-39. PubMed ID: 25637436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.
    Xu MY; Wong AHC
    Acta Pharmacol Sin; 2018 May; 39(5):733-753. PubMed ID: 29565038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evolutionarily conserved switch in response to GABA affects development and behavior of the locomotor circuit of Caenorhabditis elegans.
    Han B; Bellemer A; Koelle MR
    Genetics; 2015 Apr; 199(4):1159-72. PubMed ID: 25644702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depolarizing GABA and developmental epilepsies.
    Khazipov R; Valeeva G; Khalilov I
    CNS Neurosci Ther; 2015 Feb; 21(2):83-91. PubMed ID: 25438879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate and GABA imbalance following traumatic brain injury.
    Guerriero RM; Giza CC; Rotenberg A
    Curr Neurol Neurosci Rep; 2015 May; 15(5):27. PubMed ID: 25796572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Excitatory action of GABA in ontogenesis].
    Valeeva GR; Khazipov RN; Nikol'skiĭ EE
    Ross Fiziol Zh Im I M Sechenova; 2011 Nov; 97(11):1179-86. PubMed ID: 22390073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation of the GABAergic transmission in normal and pathologic motoneurons.
    Allain AE; Le Corronc H; Delpy A; Cazenave W; Meyrand P; Legendre P; Branchereau P
    Neural Plast; 2011; 2011():905624. PubMed ID: 21785735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis: general rules and differences in diverse systems.
    Sernagor E; Chabrol F; Bony G; Cancedda L
    Front Cell Neurosci; 2010; 4():11. PubMed ID: 20428495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA and its receptors in epilepsy.
    Sperk G; Furtinger S; Schwarzer C; Pirker S
    Adv Exp Med Biol; 2004; 548():92-103. PubMed ID: 15250588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.